Actively Recruiting

Phase Not Applicable
Age: 18Years - 45Years
FEMALE
NCT05538338

Platelet Rich Plasma for Insufficient Endometrium

Led by Reproductive Medicine Associates of New Jersey · Updated on 2025-02-07

62

Participants Needed

1

Research Sites

163 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To determine the effectiveness of an intrauterine PRP infusion on endometrial thickness and in vitro fertilization (IVF) outcomes in a population of infertile women with a history of unresponsive thin endometrium.

CONDITIONS

Official Title

Platelet Rich Plasma for Insufficient Endometrium

Who Can Participate

Age: 18Years - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients who have previously undergone at least 2 unsuccessful frozen embryo transfer cycles, defined as failure to achieve a sustained clinical pregnancy (visualization of intrauterine gestational sac on ultrasound or a cancelled embryo transfer cycle due to inadequate endometrial thickness)
  • Patients with a diagnosis of thin endometrial lining (less than or equal to 6 mm maximum thickness) during prior unsuccessful or canceled embryo transfer cycles.
Not Eligible

You will not qualify if you...

  • Fewer than 2 prior unsuccessful or canceled frozen embryo transfer cycles.
  • Most recent unsuccessful embryo transfer prior to January 1, 2017.
  • Mullerian anomalies, excluding arcuate uterus
  • Concurrent submucosal fibroids, unrepaired uterine defects or present indication for uterine surgery
  • Communicating hydrosalpinx without plans for surgical correction prior to study enrollment.
  • Failure of patient to agree to enrollment in study with written consent.
  • Concurrent pregnancy
  • Anticoagulation use for which plasma infusion is contraindicated
  • History of thrombosis
  • Thrombophilia either inherited or acquired
  • Concomitant use of adjunctive therapies for proliferation. These must be discontinued upon enrollment.
  • Embryo planned to be used for transfer generated from surgically obtained sperm due to a diagnosis of non-obstructive azoospermia
  • Recurrent/persistent endometrial fluid in prior cycles

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Reproductive Medicine Associates of New Jersey

Basking Ridge, New Jersey, United States, 07920

Actively Recruiting

Loading map...

Research Team

C

Christine V Whitehead, BSN, RN

CONTACT

C

Caroline Zuckerman, BS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here